Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish Kumar Kakkar

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Expert Opinion on Therapeutic Patents|September 16, 2015
Patent cliff mitigation strategies: giving new life to blockbustersAshish Kumar Kakkar
Science (New York, N.Y.)|April 12, 2014
India puts informed consent on cameraAshish Kumar Kakkar
Expert Opinion on Therapeutic Patents|January 13, 2021
Pharmaceutical price regulation and its impact on drug innovation: mitigating the trade-offsAshish Kumar Kakkar
Medical Hypotheses|April 22, 2014
GLP-1 receptor agonists and the risk of colorectal cancerAshish Kumar Kakkar
Journal of Family Medicine and Primary Care|July 26, 2016
Mobile health: Applications in tackling the Ebola challengeNeha Dahiya, Ashish Kumar Kakkar
North American Journal of Medical Sciences|May 21, 2014
Factors Affecting Choice of Future Specialty among Medical StudentsAshish Kumar Kakkar, Neha Dahiya
European Journal of Internal Medicine|January 31, 2015
Drug treatment of obesity: current status and future prospectsAshish Kumar Kakkar, Neha Dahiya
The Annals of Pharmacotherapy|February 13, 2014
Current issues with the use of bedaquilineAshish Kumar Kakkar, Neha Dahiya
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 16, 2014
Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designationAshish Kumar Kakkar, Sadasivam Balakrishnan
Tuberculosis (Edinburgh, Scotland)|May 21, 2014
Bedaquiline for the treatment of resistant tuberculosis: promises and pitfallsAshish Kumar Kakkar, Neha Dahiya
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Patents|September 16, 2015
Patent cliff mitigation strategies: giving new life to blockbustersAshish Kumar Kakkar
Science (New York, N.Y.)|April 12, 2014
India puts informed consent on cameraAshish Kumar Kakkar
Expert Opinion on Therapeutic Patents|January 13, 2021
Pharmaceutical price regulation and its impact on drug innovation: mitigating the trade-offsAshish Kumar Kakkar
Medical Hypotheses|April 22, 2014
GLP-1 receptor agonists and the risk of colorectal cancerAshish Kumar Kakkar
Journal of Family Medicine and Primary Care|July 26, 2016
Mobile health: Applications in tackling the Ebola challengeNeha Dahiya, Ashish Kumar Kakkar
North American Journal of Medical Sciences|May 21, 2014
Factors Affecting Choice of Future Specialty among Medical StudentsAshish Kumar Kakkar, Neha Dahiya
European Journal of Internal Medicine|January 31, 2015
Drug treatment of obesity: current status and future prospectsAshish Kumar Kakkar, Neha Dahiya
The Annals of Pharmacotherapy|February 13, 2014
Current issues with the use of bedaquilineAshish Kumar Kakkar, Neha Dahiya
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 16, 2014
Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designationAshish Kumar Kakkar, Sadasivam Balakrishnan
Tuberculosis (Edinburgh, Scotland)|May 21, 2014
Bedaquiline for the treatment of resistant tuberculosis: promises and pitfallsAshish Kumar Kakkar, Neha Dahiya
Pageof 7